957
Participants
Start Date
November 17, 2020
Primary Completion Date
December 20, 2024
Study Completion Date
September 27, 2027
Durvalumab
Human monoclonal antibody
FLOT chemotherapy
A combination treatment made up of flurouroacil + leucovorin + oxaliplatin + docetaxel
Research Site, San Isidro
Research Site, Taipei
Research Site, Taoyuan
Research Site, Kaohsiung City
Research Site, Ciudad Autonoma Buenos Aires
Research Site, Budapest
Research Site, Ciudad de Buenos Aires
Research Site, København Ø
Research Site, Edegem
Research Site, Leuven
Research Site, Rosario
Research Site, Liège
Research Site, Odense
Research Site, Szolnok
Research Site, Charleroi
Research Site, Kecskemét
Research Site, Szekszárd
Research Site, Jena
Research Site, Barcelona
Research Site, Roeselare
Research Site, Aalborg
Research Site, Győr
Research Site, Taipei
Research Site, New York
Research Site, Berlin
Research Site, Seongnam-si
Research Site, Rochester
Research Site, Hamburg
Research Site, Hamburg
Research Site, Dijon
Research Site, Besançon
Research Site, Erzurum
Research Site, Madrid
Research Site, Madrid
Research Site, Málaga
Research Site, Brest
Research Site, Ourense
Research Site, Tallahassee
Research Site, West Palm Beach
Research Site, St. Petersburg
Research Site, Istanbul
Research Site, Montpellier
Research Site, Istanbul
Research Site, Rennes
Research Site, Nashville
Research Site, Santander
Research Site, Louisville
Research Site, Taichung
Research Site, Seville
Research Site, Nantes
Research Site, Valencia
Research Site, Fort Wayne
Research Site, Mainz Am Rhein
Research Site, Samsun
Research Site, Hwasun-gun
Research Site, Frankfurt
Research Site, Heidelberg
Research Site, Lyon
Research Site, Tainan City
Research Site, Tübingen
Research Site, Heilbronn
Research Site, Paris
Research Site, Lancaster
Research Site, Dallas
Research Site, Paris
Research Site, Paris
Research Site, München
Research Site, Avignon
Research Site, Los Angeles
Research Site, Los Angeles
Research Site, Duarte
Research Site, Sylmar
Research Site, Schweinfurt
Research Site, Seattle
Research Site, Moscow
Research Site, Moscow
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Kaluga
Research Site, Obninsk
Research Site, Novosibirsk
Research Site, La Serena
Research Site, Talca
Research Site, Temuco
Research Site, Temuco
Research Site, Santiago
Research Site, Santiago
Research Site, Boston
Research Site, Buenos Aires
Research Site, Buenos Aires
Research Site, Rosario
Research Site, Barretos
Research Site, Natal
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Rio de Janeiro
Research Site, São José do Rio Preto
Research Site, São Paulo
Research Site, Edmonton
Research Site, North York
Research Site, Oshawa
Research Site, Toronto
Research Site, Montreal
Research Site, Montreal
Research Site, Nice
Research Site, Dresden
Research Site, Chūōku
Research Site, Hidaka-shi
Research Site, Hirakata-shi
Research Site, Hiroshima
Research Site, Kashiwa
Research Site, Kitaadachi-gun
Research Site, Kochi
Research Site, Kurume-shi
Research Site, Nagoya
Research Site, Niigata
Research Site, Ogaki-shi
Research Site, Osaka
Research Site, Osaka
Research Site, Suita-shi
Research Site, Sunto-gun
Research Site, Tokyo
Research Site, Toyoake-shi
Research Site, Wakayama
Research Site, Yokohama
Research Site, Amsterdam
Research Site, Eindhoven
Research Site, Rotterdam
Research Site, Bellavista
Research Site, Lima
Research Site, Lima
Research Site, Lima
Research Site, Bialystok
Research Site, Gdansk
Research Site, Krakow
Research Site, Lodz
Research Site, Poznan
Research Site, Poznan
Research Site, Warsaw
Research Site, Warsaw
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Barcelona
Research Site, Barcelona
Research Site, Adana
Research Site, Ankara
Research Site, Cambridge
Research Site, Dundee
Research Site, Glasgow
Research Site, Leicester
Research Site, London
Research Site, Manchester
Research Site, Oxford
Research Site, Surrey
Lead Sponsor
AstraZeneca
INDUSTRY